FTC, States Fight Shkreli Bid To Delay Antitrust Suit Discovery

By Julia Arciga · June 8, 2020, 7:09 PM EDT

The Federal Trade Commission and a coalition of states have pushed back against a motion by "Pharma Bro" Martin Shkreli, Vyera Pharmaceuticals, and Phoenixus AG to delay discovery in an antitrust...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al

Case Number

Court

New York Southern

Nature of Suit

Banks and Banking

Date Filed

January 27, 2020

Recent Articles By Julia

February 19, 2021
EU Clears Varian's $16.4B Sale To Siemens Unit With Fixes
February 04, 2021
Ambulance Co. Wants Full 4th Circ. To Revive Antitrust Case
January 28, 2021
9th Circ. Urged To Toss SmileDirect Harassment Suit
January 11, 2021
Becton Buyers Defend Revived Antitrust Suit
January 08, 2021
Shkreli Can't Pause Suit Pending Prison Release, Judge Says
January 07, 2021
Insurers Urge Court To Preserve Cancer Drug Antitrust Suit
January 05, 2021
Health Care Co. Appeals Contract Terminations To 6th Circ.
December 16, 2020
DEA Urges Court To Drop Whistleblower's Discrimination Case
December 10, 2020
Health Care Staffing Co. Ex-Owner Charged With Wage-Fixing
December 03, 2020
Dueling Attys Call For Xyrem MDL To Be Moved To CA Or NJ